Unknown

Dataset Information

Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosis.


ABSTRACT:

Aims

Patients hospitalized at the time of human immunodeficiency virus-associated tuberculosis (HIV-TB) diagnosis have high early mortality. We hypothesized that compared to outpatients, there would be lower anti-TB drug exposure in hospitalized HIV-TB patients, and amongst hospitalized patients exposure would be lower in patients who die or have high lactate (a sepsis marker).

Methods

We performed pharmacokinetic sampling in hospitalized HIV-TB patients and outpatients. Plasma rifampicin, isoniazid and pyrazinamide concentrations were measured in samples collected predose and at 1, 2.5, 4, 6 and 8 hours on the third day of standard anti-TB therapy. Twelve-week mortality was ascertained for inpatients. Noncompartmental pharmacokinetic analysis was performed.

Results

P

SUBMITTER: Schutz C 

PROVIDER: S-EPMC7163385 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature